PE20399A1 - Muteina ob - Google Patents

Muteina ob

Info

Publication number
PE20399A1
PE20399A1 PE00108697A PE00108697A PE20399A1 PE 20399 A1 PE20399 A1 PE 20399A1 PE 00108697 A PE00108697 A PE 00108697A PE 00108697 A PE00108697 A PE 00108697A PE 20399 A1 PE20399 A1 PE 20399A1
Authority
PE
Peru
Prior art keywords
muteina
muteins
making
methods
relates
Prior art date
Application number
PE00108697A
Other languages
English (en)
Spanish (es)
Inventor
Yves Guisez
Rene Devos
Geert Plaetinck
Der Heyden Jose Van
Sandra Verploegen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20399A1 publication Critical patent/PE20399A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PE00108697A 1996-12-06 1997-12-02 Muteina ob PE20399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96119606 1996-12-06

Publications (1)

Publication Number Publication Date
PE20399A1 true PE20399A1 (es) 1999-03-05

Family

ID=8223476

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00108697A PE20399A1 (es) 1996-12-06 1997-12-02 Muteina ob

Country Status (8)

Country Link
AR (1) AR010333A1 (fr)
AU (1) AU5654998A (fr)
CO (1) CO4930295A1 (fr)
HR (1) HRP970654A2 (fr)
MA (1) MA24411A1 (fr)
PE (1) PE20399A1 (fr)
WO (1) WO1998024896A2 (fr)
ZA (1) ZA9710832B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US6420339B1 (en) * 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US8227408B2 (en) 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
KR20110028457A (ko) 2008-05-21 2011-03-18 뉴로테즈 인코포레이티드 신경섬유 매듭과 연관된 신경변성 장애를 치료하는 방법
CA2742600A1 (fr) 2008-11-04 2010-05-14 Nikolaos Tezapsidis Compositions a base de leptine et methodes de traitement de troubles evolutifs de la fonction cognitive provoques par une accumulation d'enchevetrements neurofibrillaires et de beta-amyloide
MX349054B (es) 2010-09-28 2017-07-07 Aegerion Pharmaceuticals Inc Leptinas altamente solubles.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3483385D1 (de) * 1983-08-17 1990-11-15 Wellcome Found Physiologisch aktive zusammensetzungen.
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
EP0725079A1 (fr) * 1995-01-31 1996-08-07 Eli Lilly And Company Protéine contre obesité
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO1998024896A3 (fr) 1998-10-01
CO4930295A1 (es) 2000-06-27
WO1998024896A2 (fr) 1998-06-11
MA24411A1 (fr) 1998-07-01
ZA9710832B (en) 1998-06-08
HRP970654A2 (en) 1998-10-31
AU5654998A (en) 1998-06-29
AR010333A1 (es) 2000-06-07

Similar Documents

Publication Publication Date Title
TR200100056T2 (tr) Nörotrofik faktörler
ATE252639T1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
ID18189A (id) Dervat-derivat 6,6-hetero-bisiklik yang disubstitusi
ID18249A (id) Turunan 6,5-hetero-bisiklik tersubstitusi
GB9818916D0 (en) Use
TR199601002A1 (tr) 2-Okzo- ve 2-thio-1, 2-dihidrokinolinil-oksazolidinonlar.
DK0901488T3 (da) 2,4-diaminopyrimidinderivater
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
IL139604A0 (en) Novel peptides
SE9602822D0 (sv) New receptor
ID19571A (id) Proses pemurnian 1,4-butanadiol mentah
WO1998024896A3 (fr) Muteines de la proteine de l'obesite
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
ES1035261Y (es) Jamonero.
DE59704842D1 (de) Reihenklemme, insbesondere Initiator-Aktor-Klemme
FR2720419B1 (fr) Bloc artificiel.
IT1302971B1 (it) Procedimento di produzione per prosciutti, e mezzi relativi alprocedimento
ID16030A (id) Proses pembuatan turunan 1,5-benzotiazepin
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
ITGE960040A0 (it) Pentapeptide.
ES1033200Y (es) Linterna - caramelo.
ES1033500Y (es) Caja-expositor.
ES1034580Y (es) Pieza deslizante -saltadora.
ECSP972331A (es) Muteinas de la obesidad

Legal Events

Date Code Title Description
FA Abandonment or withdrawal